PharmaCielo Ltd. (TSXV:PCLO)

Market Cap	11.88M
Revenue (ttm)	2.60M
Net Income (ttm)	-14.03M
Shares Out	169.75M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	162,152
Average Volume	44,554
Open	0.0800
Previous Close	0.0750
Day's Range	0.0700 - 0.0800
52-Week Range	0.0650 - 0.2900
Beta	2.28
RSI	33.46
Earnings Date	Feb 14, 2025

About PharmaCielo

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. Its products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. The company has strategic partnership with B...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Marc Lustig
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: PCLO

Financial Performance

In 2023, PharmaCielo's revenue was 1.54 million, a decrease of -70.96% compared to the previous year's 5.31 million. Losses were -16.30 million, 12.3% more than in 2022.